Melanoma in Children

Riccardo Pampena

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

Year in Review 2024 - Melanoma

Oncology 2024 Year in Review

A. van Akkooi

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

Year in Review 2024 - Key Updates in Melanoma Treatment

Oncology 2024 Year in Review

T. Haykal

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

Biomarkers for Immunotherapy in Melanoma: Where Are We Now?

Vanderbilt University Medical Center (VUMC)

D. Johnson

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

The Latest and Greatest in Melanoma Treatment, 2024: From Adjuvant t…

Melanoma Research Foundation

K. Margolin

Understanding TIL Cell Therapy and the Patient Journey for Advanced …

Melanoma Research Foundation

J. Lutzky

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

Medical Treatments for Melanoma: Current and Future Options

Melanoma Research Foundation

F. Collichio

Managing Hyperglycemia During Inavolisib Therapy: Guidelines, Patien…

Doina Catrinoiu

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

Anti-IL-8 (BMS-986253) + Nivo + Ipi in Advanced Melanoma: Final Anal…

Matteo Simonelli

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters